MedPath

Needs Assessment After Cancer in Patients Treated for Breast Cancer

Completed
Conditions
Quality of Life
Fear Cancer
Breast Neoplasm Female
Registration Number
NCT03902964
Lead Sponsor
Institut Jean-Godinot
Brief Summary

observational monocentric study

Detailed Description

observational monocentric study

Primary objective :

Describe post-cancer supportive care needs, assessed by questionnaire in patients treated for breast cancer after completion of treatment and 2 years later.

Secondary objective :

* Correlation between needs after cancer and the fear of recidivism assessed by the scale of the inventory of fear.

* Compare the need for supportive care between the end of treatment and 2 years after.

* Assess needs after cancer according to the stage of the disease

* Evaluate the needs after cancer according to the treatments received: surgery-radiotherapy versus surgery-chemotherapy-radiotherapy.

* Assess needs after cancer according to age and socio-professional category.

Schedule :

The selected patients then received a letter including an information and non-objection note, the post-cancer needs questionnaire, the Fear Inventory severity subscale questionnaire, and the QLQ-C30 questionnaire. A delay of 1 month was chosen to return the questionnaire with a phone call after 15 days for an analysis of responses in February 2019.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
139
Inclusion Criteria

Women who have been treated for breast cancer and whose treatment ended in 2017 (cohort A) and in 2015 (cohort B), aged between 18 and 80 years, and who declared their non-opposition free and enlightened.

Exclusion Criteria

Patients who have been treated for recurrence or 2nd cancer, metastases from the outset, male, refusal to participate.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-cancer needs analysis2 years

Post-cancer needs analysis based on the "post-cancer needs assessment" questionnaire for patients in both cohorts

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Jean Godinot

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath